Abstract:OBJECTIVE:To study clinicopathologic features, diagnosis, treatment and prognosis of von Hippel-Lindau (VHL) syndrome-related and sporadic hemangioblastomas of the central nervous system (CNS-HB).METHODS:Histopathological, ultrastructural, immunohistochemical (EnVision method) and clinical features of 21 VHL syndrome and 63 sporadic CNS-HB cases were studied with correlation of the available follow-up information.RESULTS:Twenty-one VHL patients accompanied with a total of 87 CNS-HBs, including one patient of developing 12 HBs within 13 years. There were 10 patients presenting other lesions related to VHL, including 6 retinal HBs, 4 pancreatic tumors (endocrine tumor and microcystic cystadenoma), 1 clear renal cell carcinoma, 4 renal cysts and 1 endolymphatic sac tumor. One patient developed 5 different tumors related to VHL within a period of 4 years. In the 63 cases of sporadic CNS-HB (34 male and 29 female), the mean age was 43.0 years. Among the 18 VHL syndrome patients with available follow-up information, 14 were still alive and within them, 4 became disabled and 11 had developed new lesions. The other 4 patients died. Among the 42 patients of sporadic HB with follow-up information, 39 were alive including 3 disabled cases, and the other 3 died. Histologically, the tumors showed large and vacuolated stromal cells. Some tumors showed atypical nuclei. Involvement of the brain tissue was seen in 32 cases, among which, 21 patients with available follow-up information were learnt to be alive. Tumor cells of HB stained positive for vimentin, EGFR, Inhibin alpha and D2-40, but negative for CD34 and CD68. In 3 cases of HB, some stromal cells were positive for GFAP. All cases showed a low expression for Ki-67, except 2 cases with 2% and 1 case with 5% Ki-67 indices.CONCLUSIONS:VHL syndrome is a multisystem disorder with a poor prognosis and a high rate of missed diagnosis. The syndrome is characterized by development of various benign and malignant tumors. The most common tumor is CNS-HB, which occurs predominantly in the cerebellum. Patients with VHL syndrome tend to present at a younger age than patients with sporadic CNS-HBs, and VHL related HB occurs more predominantly in the brain stem and spinal cord. Prognosis of CNS-HB patients is not correlated with the nuclear atypicality, expression for Ki-67 and involvement of the brain tissue. Because new lesions may develop during the patient's lifetime. So that, regular clinical inspection is recommended in order to check up the development of any new lesions.

Clinicopathologic Study of Von Hippel-Lindau Syndrome-Related and Sporadic Hemangioblastomas of Central Nervous System

Hemangioblastomas of the Central Nervous System in Von Hippel-Lidau Syndrome and Sporadic Disease

Biological and Clinical Impact of Central Nervous System Hemangioblastomas in Chinese Patients with Von Hippel-Lindau Disease: Implications for Treatment

Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease

Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review

Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review

Germline mutation and clinical prognostic analysis of VHL gene in familial central nervous system hemangioblastoma

Overexpression of EGFR and TGFα in Von Hippel–Lindau-Related Central Nervous System Hemangioblastomas

Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.

Central Nervous System Hemangioblastomas: an Age-Stratified Analysis

Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients

Spinal cord hemangioblastomas in von Hippel-Lindau disease

Comprehensive treatment of von Hippel-Lindau disease: A case report

Diagnosis and treatment of renal lesions in 1 0 patients with Von Hippel-Lindau syndrome

Central Nervous System Hemangioblastomas in the Elderly (over 65 Years): Clinical Characteristics and Outcome Analysis

Clinical data analysis and long time following up in 312 cases of central nervous system hemangioblatomas

Von-Hipple Lindau syndrome with family history: a case report and seventeen years follow-up study

Distinctive Clinicopathological Features of Von Hippel-Lindau-associated Hereditary Renal Cell Carcinoma: A Single-Institution Study

Advancements in Understanding the Molecular Mechanisms and Clinical Implications of Von Hippel-Lindau Syndrome: A Comprehensive Review

Epdemiological study on familial of the central nervous system hemangioblastoma in Guizhou

Epidemiological Study of a Von Hippel-Lindau Family in Northwest China